北陆药业 (300016.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(北陆药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 207,506,078.84890,718,122.26649,819,616.22438,031,070.40188,036,687.69765,881,882.25557,308,788.59351,263,517.99183,930,040.70
 营业利润(元) 15,862,651.22-100,438,830.29-9,736,422.652,113,195.9810,281,712.65-13,282,615.2942,145,201.5738,038,884.0740,011,884.74
 利润总额(元) 15,908,255.26-101,154,683.65-9,029,256.273,073,784.1410,275,556.43-14,761,722.0840,787,050.1937,302,689.2039,475,527.56
 净利润(元) 11,621,240.12-83,200,571.05-4,214,435.414,956,020.0310,184,088.91-4,621,083.0242,188,946.0834,336,819.6034,776,332.03
 归属于母公司股东的净利润(元) 11,526,165.00-71,757,140.031,941,694.109,601,525.4912,576,111.4711,206,263.7455,234,553.2940,003,437.4439,263,324.48
盈利能力:
 销售毛利率(%) 55.6147.0148.9349.5447.6455.3958.8559.4160.25
 销售净利率(%) 5.60-9.34-0.651.135.42-0.607.579.7818.91
 净资产收益率(%) 0.67-4.190.110.530.68----
 总资产报酬率ROA(%) 1.00-2.021.030.970.77----
 投入资本回报率ROIC(%) 0.46-2.910.080.390.500.452.211.581.54
营运能力:
 存货周转率(次) 0.351.811.230.800.37----
 应收账款周转率(次) 1.556.125.193.641.77----
 总资产周转率(次) 0.070.320.230.150.06----
偿债能力:
 资产负债率(%) 37.3036.6434.3333.1532.7931.6930.0129.6028.56
 股东权益比率(%) 57.9658.5460.7661.8262.1763.0964.6262.8863.90
 已获利息倍数(倍) 2.25-1.290.761.121.850.652.413.075.52
 流动比率 3.413.333.764.244.323.894.283.914.50
 速动比率 2.622.582.893.273.272.923.142.843.45
发展能力:
 营业收入增长率(%) 10.3516.3016.6024.702.23-10.93-18.14-34.38-17.18
 营业利润增长率(%) 54.28-656.17-123.10-94.44-74.30-110.44-70.14-70.10-23.97
 税后利润增长率(%) -8.35-735.92-96.48-76.02-67.97-91.07-57.43-65.66-22.18
 净资产增长率(%) -7.04-7.08-4.13-5.97-5.66-4.34-1.531.775.76
 总资产增长率(%) -0.270.031.96-4.35-3.04-3.06-3.121.903.43

前瞻产业研究院